The 2017 Brain Tumor Biotech Summit, to be held on June 2 at Lenox Hill Hospital in New York City, brings together the nation’s top cancer specialists and the investment community to promote innovative new therapies for brain tumors. Network with researchers, oncologists, surgeons, CEOs, hedge fund managers, venture capitalists and leaders in the biotech and pharmaceutical industries. Get the latest updates on cancer treatments and learn what’s happening in clinical trials and research labs across the nation.
Come see presentations by some of the leading financial, pharmaceutical and medical authorities in the field. Special guest speakers will be Andrew Sorkin, co-anchor of CNBC’s Squawk Box; Carlos Paya, PhD, CEO of Immune Design; Eric Leuthardt, MD, professor at the Washington University School of Medicine; and Michael Lim, MD, associate professor at the Johns Hopkins University School of Medicine.
Click here to view the Brain Tumor Biotech Summit 2017 brochure.
Click here to register online for this event.
The Brain Tumor Biotech Summit is sponsored by The Feinstein Institute for Medical Research and Voices Against Brain Cancer.
The post Brain Tumor Biotech Summit 2017 appeared first on The Feinstein Institute for Medical Research.